All In Biotech

Free tool

FAERS Monitor: Nucynta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022304 or its brand name (Nucynta, Tapentadol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

31,637

Serious

29,261

92% of reports

Hospitalization

4,257

Death reported

20,703

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death11,609
  • toxicity to various agents9,935
  • overdose5,852
  • drug abuse1,540
  • drug dependence1,058
  • drug withdrawal syndrome neonatal928
  • drug ineffective799
  • accidental overdose721
  • nausea649
  • pain637
  • fatigue401
  • intentional product misuse388
  • drug interaction382
  • dizziness357
  • somnolence341

Reports by year received

View as table
YearReports
20051
20081
200998
2010155
2011339
2012306
2013294
2014299
2015754
2016885
20172,381
201821,519
2019766
2020647
2021633
2022548
2023461
2024621
2025461
2026468

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,522 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug withdrawal syndrome neonatalSignal92844.441.636,876
toxicity to various agentsSignal9,93541.640.9373,012
overdoseSignal5,85218.518.195,268
accidental overdoseSignal72113.312.48,075
drug abuseSignal1,54012.511.916,063
deathSignal11,6099.18.985,703
drug dependenceSignal1,0584.44.12,776
intentional product misuseSignal3883.02.7500
drug interaction3821.61.586
somnolence3411.11.05
pain6370.70.692
nausea6490.50.5256
dizziness3570.50.4211
drug ineffective7990.40.4754
fatigue4010.30.3526

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.